Can Huntington's disease clinical trial design tweaks lead to success?
After a series of disappointing clinical trial data in Huntington’s disease, study design changes take aim at moving the field forward.
Stay updated with breaking news from Annexon Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After a series of disappointing clinical trial data in Huntington’s disease, study design changes take aim at moving the field forward.
/PRNewswire/ -- DelveInsight's Huntington's Disease Market Insights report provides a thorough understanding of current treatment practices, emerging drugs,...
The untapped market of Huntington's Disease is anticipated to expand primarily because of the introduction of novel emerging therapies, rising prevalence and elderly population, increased R&D
/PRNewswire/ -- DelveInsight's Huntington's Disease Market Insights report provides a thorough understanding of current treatment practices, emerging drugs,...